CD4 and primary biliary cholangitis: Serum levels of interleukin (IL)-18—which acts to release IL-12 and activate the Th1 pathway—and consequent release of IFN-γ from CD4+ T cells are elevated in PBC patients compared to healthy controls [18, 19].